Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, Papakosta D, Antoniou K, Papanikolaou I, Steiropoulos P, Tomos I, Karampitsakos T, Levounets A, Fouka E, Spyropoulos G, Mastrodimou S, Papaioannou O, Kallieri M, Kosmidou N, Bizymi N, Zikos N, Dimeas I, Malli F, Daniil Z. Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients. Sarcoidosis, Vasculitis, And Diffuse Lung Diseases 2024, 41: e2024055. PMID: 39655591, DOI: 10.36141/svdld.v41i4.15661.Peer-Reviewed Original ResearchPET-CT findingsSarcoidosis patientsLikelihood of infectionInterstitial lung disease referral centersICU admissionPrevalence of SARS-CoV-2Younger ageSARS-CoV-2National multicenter studyGeneral populationInfection rateSARS-CoV-2 infectionPrevalence of SARS-CoV-2 infectionAdditional immunosuppressionCorticosteroid treatmentReferral centerMulticenter studySarcoidosisPatientsImmunosuppressionChance of infectionLonger diagnosisInfectionHospitalPrevalenceAssessment of Endothelial Function in Patients with COVID-19 Using Peripheral Arterial Tonometry
Moulias A, Koros R, Papageorgiou A, Katechis S, Patrinos P, Trigka-Vasilakopoulou A, Papageorgiou A, Papaioannou O, Akinosoglou K, Leventopoulos G, Tsigkas G, Tzouvelekis A, Davlouros P. Assessment of Endothelial Function in Patients with COVID-19 Using Peripheral Arterial Tonometry. Life 2024, 14: 1512. PMID: 39598310, PMCID: PMC11595729, DOI: 10.3390/life14111512.Peer-Reviewed Original ResearchPeripheral arterial tonometryEndothelial dysfunctionEndothelial functionCOVID-19 patientsCardiovascular complicationsArterial tonometryIncidence of thrombotic eventsAssessment of endothelial functionProportion of COVID-19 patientsProportion of patientsEvaluate endothelial functionFollow-up periodSix-month follow-upMonths post-dischargeCOVID-19-negativePrimary endpointSecondary endpointsNo significant differenceThrombotic eventsCardiovascular eventsPost-dischargeFollow-upLnRHIMatched controlsPatientsInterstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
Sampsonas F, Bosgana P, Bravou V, Tzouvelekis A, Dimitrakopoulos F, Kokkotou E. Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations. Genes 2024, 15: 934. PMID: 39062713, PMCID: PMC11276289, DOI: 10.3390/genes15070934.Peer-Reviewed Original ResearchConceptsInterstitial lung diseaseLung cancerLung diseaseDriver mutationsImproved survivalTreatment optionsChronic inflammationPathogenetic pathwaysNon-small cell lung cancerConcurrent interstitial lung diseaseCell lung cancerSites of chronic inflammationAnti-fibrotic medicationsCurrent treatment optionsIdiopathic pulmonary fibrosisDiseases associated with chronic inflammationIncidence of lung cancerPersonalized medicine approachPrompt diagnosisClinical entityNon-smallPulmonary fibrosisNSCLCSurvival ratePatientsA case report of late pleural effusion and hemoptysis as a result of pulmonary vein stenosis due to atrial fibrillation ablation
Komninos D, Sotiropoulou V, Katsaras M, Tzouvelekis A. A case report of late pleural effusion and hemoptysis as a result of pulmonary vein stenosis due to atrial fibrillation ablation. Pneumon 2024, 37: 1-4. DOI: 10.18332/pne/178471.Peer-Reviewed Original Research